SLC35A2 and osteoporosis: Findings may also be relevant to several other clinical conditions also associated with UGT KO, including solid and haematological cancers, bone mineral density and osteoporosis, and autoimmune diseases [11, 12, 16, 18, 19, 22, 30, 67, 68].